Clinical trials
Lymphoproliferative Disorders trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 7 |
| Active, not recruiting | 3 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Research UK | 6 |
| Amgen Research (Munich) GmbH | 2 |
| Pierre Fabre Medicament | 2 |
| Amgen | 1 |
| Ariad Pharmaceuticals | 1 |
| Celgene | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Nordic Nanovector | 1 |
| Novartis Pharmaceuticals | 1 |
| Spectrum Pharmaceuticals, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoproliferative Disorders | 22 |
| Neoplasms | 11 |
| Lymphoma | 9 |
| Immunoproliferative Disorders | 8 |
| Neoplasms by Histologic Type | 8 |
| Lymphatic Diseases | 7 |
| Lymphoma, Non-Hodgkin | 6 |
| Neoplasms by Site | 6 |
| Immune System Diseases | 5 |
| Hematologic Neoplasms | 4 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.